Trinity Life Sciences, a leader in global life sciences commercialization solutions, today launched a new solution that accurately predicts stakeholder behavior providing deeper insights. For the firs...
Trinity Real Insights is Now Available
WALTHAM, Mass.: Trinity Life Sciences, a leader in global life sciences commercialization solutions, today launched a new solution that accurately predicts stakeholder behavior providing deeper insights. For the first time, life sciences companies can incorporate real-world, healthcare professional (HCP)-specific prescribing behaviors with primary market research (PMR). This integration provides a view of what physicians are currently doing that is independent of what those physicians may say in market research studies.
The new solution, Trinity Real Insights, was created by experts with deep life sciences commercialization knowledge. Within market research studies, stated behaviors by physicians may be out of their control or contain inaccuracies from recall or bias. In contrast, the analytics in RWD studies don’t necessarily account for perceptions, beliefs and attitudes. By default, it is a historical view. Real Insights contains the best of both types of research: stakeholder self-reports AND the behavioral data to explain and predict based on the “why.”
Trinity Real Insights can answer the types of questions life sciences executives are asking:
“It is now possible to combine primary and secondary real-world data into a single source of truth that optimally supports robust, accurate decision-making,” explained Aparna Deshpande, Senior Partner and Head of Insights at Trinity Life Sciences. “With Trinity Real Insights, our team of PhD-level experts have developed AIML and predictive methods to tackle complex questions efficiently through this type of integrated data asset.”
Rooting predictions in reality boosts confidence in the estimates and outputs. A data-agnostic approach, which identifies, recommends and uses the RWD that best fits each question, allows for seamless integration of secondary/claims data with survey data at the HCP level.
“Each client’s situation is unique. Selecting the data sources that best suit the client and their business question, rather than relying on a single source, allows us to build predictive insights that can be confidently explained,” added Clive Mendonca, Managing Director and Head of Quantitative Insights at Trinity Life Sciences. “And the Real Insights approach is durable—these physician insights can be used by brands to enrich all subsequent studies.”
Trinity Real Insights
Trinity Real Insights allows for confident understanding and prediction of future stakeholder decisions through expert integration of PMR and RWD and the novel application of the resulting insights. Clinigraphics, patient mix and relevant prescribing behaviors are grounded in RWD to add an objective lens and a tether to reality. PMR captures the “whys” and “hows” behind current behaviors and future intentions. Trinity deploys AIML-based predictive models to generate an HCP decision map and predict future behavior, including identifying key targets of interest.
Real Insights allows insights and analytics teams to:
Webinar: RWD + PMR
Predictive insights on stakeholder behavior are crucial, whether for demand assessments, segmentation, message testing, market mapping or ATUs—and the more rooted in reality these predictions are, the more confidence in the estimates and outputs. A webinar on May 14, RWD + PMR: A Powerful Approach to Demand Forecasting, Segmentation and More, will discuss the applications and benefits of using integrated insights from PMR and RWD.
For more information or to register, click here.
Infographic Now Available
Trinity experts map out how integrated insights from PMR and RWD can improve prediction of future market share estimates by nearly 20 times in the new infographic: RWD + PMR = Tethering Demand Forecasts to Reality.
Life sciences executives are welcome to access the infographic here.
About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With more than 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.
Fonte: Business Wire
Scheduled for October, the world's largest startup event will bring together more than 2,000 exhibitors in Dubai, UAE
The Italian IoT company is in the US for the second phase of CALL4INNOVIT
The Italian company partners with MainStreaming for high-performance, energy-efficient video streaming
Software vendors developing vertical solutions against specific attack vectors are 'cool' again. And when it comes to email security, all companies now…
The "New Zealand Buy Now Pay Later Business and Investment Opportunities Databook - Q2 2024 Update" report has been added to ResearchAndMarkets.com's…
The "Kenya Buy Now Pay Later Business and Investment Opportunities Databook - 75+ KPIs on BNPL Market Size, End-Use Sectors, Market Share, Product Analysis,…
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) will host two live webcasts on September 5, 2024.…
RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces that Mark Lawyer has joined…